To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive
a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles.
Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive
evaluation and ratings from patients.
Susan G. Komen Medical Co-Director of Philly Pops Event for Minority Women 2016
Susan G. Komen/American Association of Cancer Research Outstanding Investigator Award 2016
Susan G. Komen Medical Co-Director of Philly Pops Event for Minority Women 2017
Susan G. Komen Jamie Brooke Lieberman Award 2020
I am acutely aware of the impact that a breast cancer diagnosis has on an individual. I do my best to foster a positive environment in which to start my patients' course of treatment and take the time to explain the pros and cons of each treatment option, so that they can make an informed decision. My treatment philosophy also includes, not just an emphasis on successful treatment, but also preserving a good cosmetic outcome. I feel fortunate to be a fellowship trained, very highly specialized clinician practicing at Fox Chase Cancer Center, which is an NCI-Designated Comprehensive Cancer Center, because this combination of factors allows me, and our treatment team, to focus on one thing all day, every day, and do it well: curing breast cancer. Additionally, what may be rarely seen by others, such as unusual pathology results, complex cases, or rare clinical situations (such as male breast cancer or breast cancers whose primary tumor cannot be found), I see frequently. I enjoy using that experience to help individuals where it may be hard for them to find expertise for their specific concern. When it comes to curing breast cancers of all types, I think there is nothing more rewarding that I could do as a clinician.
There were a lot of things going on in my life when I first found a lump in my breast. My mother-in-law was in failing health, my two children were teenagers, and I was separating with my husband of 23 years. My life was in chaos; when I found the lump, it further added to that.
I’m 65 years old, and thanks to a 35-year career at the Department of Defense, I’ve been happily retired for just about a decade. I live in Willow Grove, Pennsylvania, with my husband Bill, our dog Tess, short for Tess the Mess, and our cat Amoco, who is named for the gas station where we found her.
When I was growing up in Philadelphia’s Olney-Feltonville neighborhood, my grandmother made sure I knew how to run a household. She taught all of her grandchildren how to do essential household tasks, like sewing and cooking. I always looked forward to the day when I’d get to follow in her footsteps and pass these skills along to my son, Alex.
But when I was diagnosed with breast cancer in 2015 at age 43, I found myself worried about whether I would be able to carry on family traditions like this.
At 36, Patti Rose, a wife and mother to seven children, was shocked to learn she had a rare form of breast cancer. Because her husband works in construction and had done several projects for Fox Chase Cancer Center, they knew right away Fox Chase was the right place for Patti's treatment. At Fox Chase, Patti underwent chemotherapy and radiation therapy, followed by a lumpectomy and additional surgery. The experience was extremely difficult, but Patti credits the staff at Fox Chase for giving her a positive outlook and helping her get through it. Today, she is cancer free and could not be more pleased with the treatment she received. "Fox Chase helped me to be positive. If I didn’t have that connection with doctors and nurses and even the security guard that I would talk to every time I was there, I think I would have felt more afraid," she said. "Knowing all those people were praying for me, thinking of me, and trying to get me through it made me feel like I could overcome it."
Health services research, breast imaging, breast cancer, population studies; Sentinel node biopsy in breast cancer; Novel treatment modalities for breast cancer; Breast cancer clinical trials; Breast imaging and cancer outcomes, Disparities in breast cancer, Male and female breast cancer.
Jordan, RM, Rivera-Sanchez L, Kelley K, O’Brien MA, Ruth K, Porpiglia AS, Aggon AA, Ross E, Sigurdson ER, Bleicher RJ. The Impact of an Electromagnetic Seed Localization Device as versus Wire Localization on Breast Conserving Surgery: A Matched Pair Analysis. Ann Surg Oncol 2023; 30 (7), 4111-4119. https://pubmed.ncbi.nlm.nih.gov/37012435/
Bleicher R.J., Moran M.S., Ruth K., Edge S.B., Dietz J.M., Wilke L.G., Stearns V., Kurtzman S.H., Klein J., Yao K.A., The impact of radiotherapy delay in breast conservation patients not receiving chemotherapy and the rationale for dichotomizing the radiation oncology time-dependent standard into two quality measures. Ann Surg Oncol. 29(1): 469-481, 2022.PMC9059503. https://www.ncbi.nlm.nih.gov/pubmed/34324114.
Williams A.D., Chang C., Sigurdson E.R., Wang C.H., Aggon A.A., Hill M.V., Porpiglia A., Bleicher R.J., Neoadjuvant endocrine therapy and delays in surgery for ductal carcinoma in situ: Implications for the coronavirus pandemic. Ann Surg Oncol. 29(3): 1683-1691, 2022.PMC8504964. https://www.ncbi.nlm.nih.gov/pubmed/34635974.
Sharp N.E., Sachs D.B., Melchior N.M., Albaneze P., Nardello S., Sigurdson E.R., Deng M., Aggon A.A., Daly J.M., Bleicher R.J., Does the false-negative rate for 1 or 2 negative sentinel nodes after neo-adjuvant chemotherapy translate into a high local recurrence rate? Breast J. 27(4): 335-344, 2021.PMC8927898. https://www.ncbi.nlm.nih.gov/pubmed/33709448.
Esposito AC, Crawford J, Sigurdson ER, Handorf EA, Hayes SB, Boraas M, Bleicher RJ. Omission of radiotherapy after breast conservation surgery in the postneoadjuvant setting. Journal of Surgical Research, 221:49-57, 2018. PMC5729922
Bleicher RJ, Ruth K, Sigurdson ER, Beck RJ, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL. Time to surgery and breast cancer survival in the United States. In Press, JAMA Oncol 2015
Bleicher RJ, Ruth K, Sigurdson ER, Daly JM, Boraas M, Anderson P, Egleston BL. Breast Conservation Versus Mastectomy for T3 Primaries (>5 cm): A Review of 5,685 Medicare Patients. In Press, Cancer 2015.
Bleicher RJ. Reply to E. Peralta, et al. re: Breast MRI as it is, in contrast to how we wish it to be. J Clin Oncol 2014; 32, 2818-2819.
Loveland-Jones C, Ruth K, Sigurdson ER, Egleston BL, Boraas M, Bleicher RJ. Breast conservation surgery in the Medicare patient: Will the American College of Surgeons Oncology Group Z0011 Trial change the pattern of care? Br Cancer Res Treat 2014; 143, 571-7. [DOI 10.1007/s10549-014-2834-9, PubMed]
Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL. Preoperative delays in the United States Medicare population having breast cancer. J Clin Oncol 2012; 30, 4485-92. [DOI 10.1200/JCO.2012.41.7972, PubMed]
Crivello M, Ruth K, Egleston BL, Sigurdson ER, Wong YN, Boraas M, Bleicher RJ. Advanced imaging modalities in early stage breast cancer– preoperative use in the United States Medicare Patient. Ann Surg Oncol 2013; 20: 102-10. [DOI 10.1245/s10434-012-2571-4, PubMed]...Expand
Patel RR, Li T, Ross EA, Sesa L, Sigurdson ER, Bleicher RJ. The effect of simultaneous peripheral excision in breast conservation upon margin status. Ann Surg Oncol 2010; 17, 2933-9. [DOI: 10.1245/s10434-010-1123-z, PubMed, NIHMS: 200283]
Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, Morrow M. The association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009; 209: 180-187. Quiz 294-5. [DOI: 10.1016/j.jamcollsurg.2009.04.010, PubMed
Bleicher RJ, Kloth DD, Robinson D, Axelrod P. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy. J Surg Oncol 2009; 99:356-60. [DOI: 10.1002/jso.21240, PubMed]
Bleicher RJ, Topham NS, Morrow M. Beauty and the beast: Management of breast cancer after plastic surgery. Ann Surg 2008; 247:680-6. [DOI: 10.1097/SLA.0b013e318161b40f, PubMed] Collapse
The following ratings and reviews are based on verified feedback collected from independently administered
patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions.
Patient identities are withheld to ensure confidentiality and privacy.
Learn more about our Patient Experience Ratings.